| Regional Prophylactic Vancomycin With Restricted Tourniquet Time in Primary Total Knee Replacement (NCT03506347) | Mayo Clinic | 2018-09-24 |
| REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma (NCT03690869) | Regeneron Pharmaceuticals | 2018-09-24 |
| Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE Study (NCT03639311) | ViiV Healthcare | 2018-09-24 |
| Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046) (NCT03631407) | Merck Sharp & Dohme LLC | 2018-09-24 |
| Protein Plus: Improving Infant Growth Through Diet and Enteric Health (NCT03683667) | Johns Hopkins Bloomberg School of Public Health | 2018-09-23 |
| Use of Topical Solasodine of Solanum Melongena Peel Origin in the Treatment of Palmar Arsenic Keratosis (NCT04693000) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2018-09-23 |
| A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancer (NCT03587285) | Guangzhou University of Traditional Chinese Medicine | 2018-09-23 |
| The Influence of Vascular Burden, Amyloid Plaque and Tau Protein in Patients With Vascular Cognitive Impairment and Dementia With Tauopathy (NCT04309253) | Chang Gung Memorial Hospital | 2018-09-21 |
| Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis French Part of the Main Bev-IP Study (NCT03161041) | Hospices Civils de Lyon | 2018-09-21 |
| A Study of Obinutuzumab (RO5072759) Induction in Patients With Relapsed/ Refractory Waldenström Macroglobulinemia, OBI-1 (NCT03679455) | Polish Myeloma Consortium | 2018-09-21 |
| Imaging Immune Activation in HIV by PET-MR (NCT03684655) | CellSight Technologies, Inc. | 2018-09-21 |
| The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis (NCT03638258) | Arcutis Biotherapeutics, Inc. | 2018-09-21 |
| Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine (NCT03527238) | University of Florida | 2018-09-21 |
| Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis (NCT03355365) | Tisch Multiple Sclerosis Research Center of New York | 2018-09-21 |
| Plasma Lipoprotein Response to Glucagon-like Peptide-2 (NCT03422666) | University Health Network, Toronto | 2018-09-21 |
| Dual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma) (NCT03648489) | Imperial College London | 2018-09-21 |
| Pilot of a Prebiotic and Probiotic Trial in Young Infants With Severe Acute Malnutrition (NCT03666572) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2018-09-21 |
| CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation (NCT03911193) | Fondazione Ricerca Traslazionale | 2018-09-21 |
| VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions (NCT03603808) | AIDS Malignancy Consortium | 2018-09-21 |
| A Study to Evaluate the Safety and Efficacy of Itacitinib in Moderate to Severe Ulcerative Colitis (NCT03627052) | Incyte Corporation | 2018-09-20 |
| Safety, Tolerability, and Pharmacokinetics of Clesrovimab (MK-1654) in Infants (MK-1654-002) (NCT03524118) | Merck Sharp & Dohme LLC | 2018-09-20 |
| Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma (NCT03731832) | GWT-TUD GmbH | 2018-09-20 |
| Combination of Nanoxel and Herzuma in Salivary Duct Carcinoma (NCT03614364) | Samsung Medical Center | 2018-09-20 |
| The Role of VitD in Rehabilitation of Idiopathic Adolescent Scoliosis (NCT03582917) | University of Ioannina | 2018-09-20 |
| Radiotherapy With Double Checkpoint Blockade of Locally Advanced HNSCC (NCT03426657) | University of Erlangen-Nürnberg Medical School | 2018-09-20 |
| A Pilot Study to Assess the Safety of Oral Insulin in Patients With Nonalcolholic Steatohepatitis (NASH) (NCT02653300) | Oramed, Ltd. | 2018-09-20 |
| To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) (NCT03544281) | GlaxoSmithKline | 2018-09-20 |
| KPL-301 for Subjects With Giant Cell Arteritis (NCT03827018) | Kiniksa Pharmaceuticals, Ltd. | 2018-09-20 |
| Neoadjuvant mFOLFOXIRI for Potentially Resectable Cholangiocarcinoma (NCT03603834) | Khon Kaen University | 2018-09-19 |
| Methylphenidate and Cognitive Training in Elderly (NCT03280251) | University Hospital, Lille | 2018-09-19 |
| Efficacy and Safety of GnRH Analogue Triptorelin for HIV-1 Reservoir Reduction in ART Treated HIV-1 Infected Patients (NCT03536234) | Immune System Regulation AB | 2018-09-19 |
| Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects (NCT03742492) | Universidade do Porto | 2018-09-19 |
| Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid Tumors (NCT03736889) | BeiGene | 2018-09-19 |
| 2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies (NCT03712878) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2018-09-19 |
| Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer (NCT03617913) | Mayo Clinic | 2018-09-19 |
| Multicenter Study to Evaluate the Effect of BTI320 on Glycemic Control in Type 2 Diabetes (NCT03655535) | Boston Therapeutics | 2018-09-19 |
| Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers (NCT03589729) | M.D. Anderson Cancer Center | 2018-09-19 |
| DEPLETHINK - LymphoDEPLEtion and THerapeutic Immunotherapy With NKR-2 (NCT03466320) | Celyad Oncology SA | 2018-09-18 |
| Pembrolizumab & Cabozantinib in Patients With Head and Neck Squamous Cell Cancer (NCT03468218) | Emory University | 2018-09-18 |
| Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS) (NCT03944252) | Gruppo Oncologico del Nord-Ovest | 2018-09-18 |
| Study of Anlotinib Combined With Gemcitabine/Cisplatin in Advanced Nasopharyngeal Carcinoma (NCT03639467) | Chinese Academy of Medical Sciences | 2018-09-18 |
| RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2 (NCT04524026) | Nicholas Macklon | 2018-09-18 |
| A Study to Assess Safety and Efficacy of KarXT in Adult Patients With Schizophrenia (NCT03697252) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2018-09-18 |
| Cabozantinib Plus Pembrolizumab as First-Line Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma (NCT03534804) | University of Utah | 2018-09-18 |
| A Study to Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1) (NCT03669393) | ThromboGenics | 2018-09-18 |
| CV301 Combined With PD-1/L1 Blockade in Patients With Locally Advanced or Metastatic Urothelial Bladder Cancer (NCT03628716) | Bavarian Nordic | 2018-09-18 |
| Investigation of Efficacy of Secukinumab in Patients With Moderate to Serve Atopic Dermatitis (NCT03568136) | GWT-TUD GmbH | 2018-09-18 |
| Injection Techniques of Collagenase Clostridium Histolyticum (CCH) for the Treatment of EFP (Cellulite) (NCT03632993) | Endo USA Inc., a Keenova Therapeutics Company | 2018-09-18 |
| Enasidenib and Azacitidine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia and IDH2 Gene Mutation (NCT03683433) | M.D. Anderson Cancer Center | 2018-09-18 |
| Systemic and Local Antimicrobials in the Management of Dental Abscess in Children (NCT03761264) | University of Malaya | 2018-09-18 |
| Topical Minocycline Gel for Inflammatory Lesions of Papulopustular Rosacea (NCT03667222) | BioPharmX, Inc. | 2018-09-18 |
| Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery (NCT03545516) | Richmond University Medical Center | 2018-09-17 |
| Relieving Acute Pain (RAP) Study: A Pilot Study (NCT03426137) | University of Maryland, Baltimore | 2018-09-17 |
| Gent for Pharyngeal Gonorrhea (GC) (NCT03632109) | University of Washington | 2018-09-17 |
| Chloroquine (CQ) and Azithromycin (AZ) Combination for Malaria Prophylaxis (NCT03278808) | U.S. Army Medical Research and Development Command | 2018-09-17 |
| Pilot Human Lab Study of Lacosamide in Alcohol Use Disorder (AUD) (NCT03897348) | University of California, San Francisco | 2018-09-17 |
| Vasopressin and Pain Perception in the Brain (NCT03446456) | University of Maryland, Baltimore | 2018-09-17 |
| Chemotherapy and G-CSF for Mobilization (NCT03442673) | Insel Gruppe AG, University Hospital Bern | 2018-09-17 |
| Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin (NCT03857399) | Cttq | 2018-09-17 |
| Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest (NCT03640949) | Lars Wiuff Andersen | 2018-09-17 |
| This Study is Done in Patients With Plaque Psoriasis and Tests How Well They Tolerate BI 730357 and How Effective it is (NCT03635099) | Boehringer Ingelheim | 2018-09-17 |
| Endemic Mycoses Treatment With SUBA-itraconazole vs Itraconazole (NCT03572049) | University of Alabama at Birmingham | 2018-09-17 |
| Study of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer (NCT03475004) | University of Colorado, Denver | 2018-09-17 |
| A Study of OV101 in Individuals With Fragile X Syndrome (NCT03697161) | Healx AI | 2018-09-17 |
| Omacetaxine + Azacitidine in Untreated Patients With High Grade MDS (NCT03564873) | University of Colorado, Denver | 2018-09-17 |
| Liposome Bupivacaine Interscalene Total Shoulder (NCT03587636) | University of Minnesota | 2018-09-17 |
| Immunotherapy in Combination With Chemotherapy in Small-cell Lung Cancer (NCT03568097) | Hellenic Cooperative Oncology Group | 2018-09-16 |
| Apatinib Combined With S-1 in the Second-line Treatment of Advanced Pancreatic Cancer (NCT03662035) | Changzhou No.2 People's Hospital | 2018-09-15 |
| Study of the Safety and Efficacy of APR-246 in Combination With Azacitidine (NCT03588078) | Groupe Francophone des Myelodysplasies | 2018-09-15 |
| Clinical Study of Bivalirudin for Percutaneous Coronary Intervention (PCI) (NCT03567408) | Qian Gong | 2018-09-15 |
| A Double-Blind, Placebo-Controlled Safety and Efficacy Study of NA-831 (NCT03538522) | Biomed Industries, Inc. | 2018-09-15 |
| Addition of Gemcitabine to Pre Allo-HSCT Conditioning for Acute Lymphoblastic Leukemia (NCT03339700) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2018-09-15 |
| Use of Intranasal Oxytocin During Detoxification of Crack Cocaine (NCT04306354) | Pontificia Universidade Católica do Rio Grande do Sul | 2018-09-15 |
| Anesthetic Efficacy of 2% Mepivacaine Versus 4% Articaine (NCT03725579) | Cairo University | 2018-09-15 |
| MitoQ for Fatigue in Multiple Sclerosis (NCT03166800) | Oregon Health and Science University | 2018-09-15 |
| Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness (NCT06443827) | Azienda Sanitaria dell'Alto Adige | 2018-09-15 |
| Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking? (NCT03588754) | Yale University | 2018-09-15 |
| A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors (NCT03707340) | Memorial Sloan Kettering Cancer Center | 2018-09-14 |
| The ELiSA Study - Evaluation of Lixivaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (NCT03487913) | Palladio Biosciences | 2018-09-14 |
| A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer (NCT03694522) | Five Prime Therapeutics, Inc. | 2018-09-14 |
| Study of Atezolizumab + FLOT vs. FLOT Alone in Patients With GC/GEJ and High Immune Responsiveness (NCT03421288) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2018-09-14 |
| A Safety and Efficacy Study Evaluating CTX001 in Participants With Transfusion-Dependent β-Thalassemia (NCT03655678) | Vertex Pharmaceuticals Incorporated | 2018-09-14 |
| Vitamin C & Thiamine to Treat Sepsis and Septic Shock (NCT03592277) | Trinity Health Of New England | 2018-09-14 |
| Study to Assess the Safety and Biological Activity of AMX0035 for the Treatment of Alzheimer's Disease (NCT03533257) | Amylyx Pharmaceuticals Inc. | 2018-09-14 |
| Study of VERU-944 to Ameliorate Hot Flashes in Men With Advanced Prostate Cancer (NCT03646162) | Veru Inc. | 2018-09-14 |
| Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm (NCT03531918) | Fred Hutchinson Cancer Center | 2018-09-14 |
| CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children (NCT04224571) | Chinese University of Hong Kong | 2018-09-14 |
| The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients (NCT03292861) | Cedars-Sinai Medical Center | 2018-09-13 |
| Embolization for the Treatment of Pain Secondary to Adhesive Capsulitis (NCT03676829) | Vascular Institute of Virginia | 2018-09-13 |
| Efficacy of Treatment of Postpartum Anaemia With Intravenous Iron Versus Oral Iron in a Tertiary Hospital in South East, Nigeria. (NCT07110935) | Federal Teaching Hospital Abakaliki | 2018-09-13 |
| Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in Participants With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands (NCT03548415) | Ionis Pharmaceuticals, Inc. | 2018-09-13 |
| Rifaximin Soluble Solid Dispersion (SSD) Tablets Plus Lactulose for the Treatment of Overt Hepatic Encephalopathy (OHE) (NCT03515044) | Bausch Health Americas, Inc. | 2018-09-13 |
| Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma (NCT03681561) | Veronika Bachanova | 2018-09-13 |
| Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) (NCT03837301) | National Cancer Center, Korea | 2018-09-12 |
| Neuro Biomarkers of Smoking Behavior (NCT03811951) | University of Illinois at Chicago | 2018-09-12 |
| Doxycycline for Hereditary Hemorrhagic Telangiectasia (NCT03397004) | Unity Health Toronto | 2018-09-12 |
| Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor (GIST) (NCT03556384) | Adam Burgoyne, MD, PhD | 2018-09-12 |
| Safety, Pharmacokinetics and Preliminary Efficacy Study of CFZ533 in Patients With Lupus Nephritis. (NCT03610516) | Novartis Pharmaceuticals | 2018-09-12 |
| Olaparib Before Surgery in Treating Participants With Localized Prostate Cancer (NCT03570476) | University of Washington | 2018-09-11 |
| A Phase 2 Study of Sitravatinib in Combination With PD-(L)1 Checkpoint Inhibitor Regimens in Patients With Advanced or Metastatic Urothelial Carcinoma (NCT03606174) | Mirati Therapeutics Inc. | 2018-09-11 |